SWOG clinical trial number
SWOG-9249
Intensive Carboplatin/Cyclophosphamide/G-CSF Therapy Followed by Either Standard Dose Paclitaxel (Taxol®) or Intensive Paclitaxel (Taxol®)/G-CSF for Patients with Stage III Suboptimal Disease Ovarian Cancer, Phase III
Closed
Phase
Accrual
18%
Abbreviated Title
Intensive Carboplatin/Cyclophosphamide/G-CSF Therapy Followed by Either Standard Dose Paclitaxel (Taxol®) or Intensive Paclitaxel (Taxol®)/G-CSF for Patients with Stage III Suboptimal Disease Ovarian…
Activated
03/15/1995
Closed
07/01/1998